These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 39137015

  • 41. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H, Wiechert F, Luebbert C, Sadowski G.
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [Abstract] [Full Text] [Related]

  • 42. Investigating the effects of excipients on the powder flow characteristics of theophylline anhydrous powder formulations.
    Nagel KM, Peck GE.
    Drug Dev Ind Pharm; 2003 Mar; 29(3):277-87. PubMed ID: 12741609
    [Abstract] [Full Text] [Related]

  • 43. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J, Langdon BA, Hicks I, Song D, Li F, Kathiria L, Kane A, Ranade G, Agarwal K.
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
    Bostijn N, Van Renterghem J, Vanbillemont B, Dhondt W, Vervaet C, De Beer T.
    Eur J Pharm Sci; 2019 Apr 30; 132():106-117. PubMed ID: 30831193
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Applications of excipients in the field of 3D printed pharmaceuticals.
    Tian P, Yang F, Yu LP, Lin MM, Lin W, Lin QF, Lv ZF, Huang SY, Chen YZ.
    Drug Dev Ind Pharm; 2019 Jun 30; 45(6):905-913. PubMed ID: 30744433
    [Abstract] [Full Text] [Related]

  • 49. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment.
    Koranne S, Lalge R, Suryanarayanan R.
    Mol Pharm; 2020 Apr 06; 17(4):1324-1334. PubMed ID: 32142293
    [Abstract] [Full Text] [Related]

  • 50. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment.
    Koranne S, Sahoo A, Krzyzaniak JF, Luthra S, Arora KK, Suryanarayanan R.
    Mol Pharm; 2018 Aug 06; 15(8):3297-3307. PubMed ID: 29947519
    [Abstract] [Full Text] [Related]

  • 51. Development of Maltodextrin-Based Immediate-Release Tablets Using an Integrated Twin-Screw Hot-Melt Extrusion and Injection-Molding Continuous Manufacturing Process.
    Puri V, Brancazio D, Desai PM, Jensen KD, Chun JH, Myerson AS, Trout BL.
    J Pharm Sci; 2017 Nov 06; 106(11):3328-3336. PubMed ID: 28684263
    [Abstract] [Full Text] [Related]

  • 52. Insights on the role of excipients and tablet matrix porosity on aspirin stability.
    Veronica N, Liew CV, Heng PWS.
    Int J Pharm; 2020 Apr 30; 580():119218. PubMed ID: 32165224
    [Abstract] [Full Text] [Related]

  • 53. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
    S'ari M, Blade H, Cosgrove S, Drummond-Brydson R, Hondow N, Hughes LP, Brown A.
    Mol Pharm; 2021 May 03; 18(5):1905-1919. PubMed ID: 33797925
    [Abstract] [Full Text] [Related]

  • 54. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract].
    Zgoda MM, Nachajski MJ, Kołodziejczyk MK.
    Polim Med; 2009 May 03; 39(1):17-30. PubMed ID: 19580170
    [Abstract] [Full Text] [Related]

  • 55. Dependence of Friability on Tablet Mechanical Properties and a Predictive Approach for Binary Mixtures.
    Paul S, Sun CC.
    Pharm Res; 2017 Dec 03; 34(12):2901-2909. PubMed ID: 28983779
    [Abstract] [Full Text] [Related]

  • 56. To study physical compatibility between dibasic calcium phosphate and cohesive actives using powder rheometer and thermal methods.
    Trivedi MR, Dave RH.
    Drug Dev Ind Pharm; 2014 Dec 03; 40(12):1585-96. PubMed ID: 24099552
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Leucine as a Moisture-Protective Excipient in Spray-Dried Protein/Trehalose Formulation.
    Zhang C, van de Weert M, Bjerregaard S, Rantanen J, Yang M.
    J Pharm Sci; 2024 Sep 03; 113(9):2764-2774. PubMed ID: 38944343
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A formulation strategy for solving the overgranulation problem in high shear wet granulation.
    Osei-Yeboah F, Zhang M, Feng Y, Sun CC.
    J Pharm Sci; 2014 Aug 03; 103(8):2434-40. PubMed ID: 24985120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.